CMRX Price Targets and Analyst Ratings NASDAQ:CMRX
CMRX Forecast. What You Should Know.
CMRX Historical Ratings and Targets
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midl... CMRX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.